Literature DB >> 27049784

Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.

Dario Ribero1, Giuseppe Zimmitti1, Thomas A Aloia1, Junichi Shindoh1, Forchino Fabio1, Marco Amisano1, Guillaume Passot1, Alessandro Ferrero1, Jean-Nicolas Vauthey1.   

Abstract

BACKGROUND: The highest mortality rates after liver surgery are reported in patients who undergo resection for hilar cholangiocarcinoma (HCCA). In these patients, postoperative death usually follows the development of hepatic insufficiency. We sought to determine the factors associated with postoperative hepatic insufficiency and death due to liver failure in patients undergoing hepatectomy for HCCA. STUDY
DESIGN: This study included all consecutive patients who underwent hepatectomy with curative intent for HCCA at 2 centers, from 1996 through 2013. Preoperative clinical and operative data were analyzed to identify independent determinants of hepatic insufficiency and liver failure-related death.
RESULTS: The study included 133 patients with right or left major (n = 67) or extended (n = 66) hepatectomy. Preoperative biliary drainage was performed in 98 patients and was complicated by cholangitis in 40 cases. In all these patients, cholangitis was controlled before surgery. Major (Dindo III to IV) postoperative complications occurred in 73 patients (55%), with 29 suffering from hepatic insufficiency. Fifteen patients (11%) died within 90 days after surgery, 10 of them from liver failure. On multivariate analysis, predictors of postoperative hepatic insufficiency (all p < 0.05) were preoperative cholangitis (odds ratio [OR] 3.2), future liver remnant (FLR) volume < 30% (OR 3.5), preoperative total bilirubin level >3 mg/dL (OR 4), and albumin level < 3.5 mg/dL (OR 3.3). Only preoperative cholangitis (OR 7.5, p = 0.016) and FLR volume < 30% (OR 7.2, p = 0.019) predicted postoperative liver failure-related death.
CONCLUSIONS: Preoperative cholangitis and insufficient FLR volume are major determinants of hepatic insufficiency and postoperative liver failure-related death. Given the association between biliary drainage and cholangitis, the preoperative approach to patients with HCCA should be optimized to minimize the risk of cholangitis.
Copyright © 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27049784      PMCID: PMC4925184          DOI: 10.1016/j.jamcollsurg.2016.01.060

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  42 in total

1.  Total and segmental liver volume variations: implications for liver surgery.

Authors:  Eddie K Abdalla; Alban Denys; Patrick Chevalier; Rabih A Nemr; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2004-04       Impact factor: 3.982

2.  Modified Makuuchi incision for foregut procedures.

Authors:  Sharon B Chang; Martin Palavecino; Curtis J Wray; Yoji Kishi; Peter W T Pisters; Jean-Nicolas Vauthey
Journal:  Arch Surg       Date:  2010-03

Review 3.  Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care.

Authors:  David C Madoff; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  J Vasc Interv Radiol       Date:  2005-06       Impact factor: 3.464

4.  Perioperative total parenteral nutrition in surgical patients.

Authors: 
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

Review 5.  Recent advances in the management of cholangiocarcinomas.

Authors:  J N Vauthey; L H Blumgart
Journal:  Semin Liver Dis       Date:  1994-05       Impact factor: 6.115

6.  Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival.

Authors:  T M van Gulik; J J Kloek; A T Ruys; O R C Busch; G J van Tienhoven; J S Lameris; E A J Rauws; D J Gouma
Journal:  Eur J Surg Oncol       Date:  2010-11-27       Impact factor: 4.424

7.  Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use?

Authors:  Dario Ribero; Marco Amisano; Francesca Bertuzzo; Serena Langella; Roberto Lo Tesoriere; Alessandro Ferrero; Daniele Regge; Lorenzo Capussotti
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

8.  Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver.

Authors:  J J Kloek; H A Marsman; A K van Vliet; D J Gouma; T M van Gulik
Journal:  Surgery       Date:  2008-07       Impact factor: 3.982

Review 9.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

10.  Preoperative biliary drainage for biliary tract and ampullary carcinomas.

Authors:  Masato Nagino; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Tatsuya Yoshikawa; Tetsuo Ohta; Fumio Kimura; Takehiro Ohta; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more
  32 in total

1.  Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma.

Authors:  Robert Js Coelen; Joost Huiskens; Pim B Olthof; Eva Roos; Jimme K Wiggers; Annuska Schoorlemmer; Otto M van Delden; Heinz-Josef Klümpen; Erik Aj Rauws; Thomas M van Gulik
Journal:  United European Gastroenterol J       Date:  2016-09-30       Impact factor: 4.623

Review 2.  [Surgical approach to benign bile duct alterations].

Authors:  A Alvanos; S Rademacher; A Hoffmeister; D Seehofer
Journal:  Chirurg       Date:  2020-01       Impact factor: 0.955

3.  Benefit to Perform Indocyanine Green Clearance Test: Reply.

Authors:  Yukihiro Yokoyama; Masato Nagino
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

4.  East or West, Who Grades Liver Failure After Liver Resection for Perihilar Cholangiocarcinoma Best?

Authors:  Pim B Olthof; Robert J S Coelen; Thomas M van Gulik
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

5.  Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct Cancer.

Authors:  Masayuki Akita; Tetsuo Ajiki; Taku Matsumoto; Kenta Shinozaki; Tadahiro Goto; Sadaki Asari; Hirochika Toyama; Masahiro Kido; Takumi Fukumoto; Yonson Ku
Journal:  J Gastrointest Surg       Date:  2017-03-13       Impact factor: 3.452

6.  Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution.

Authors:  Yoshitsugu Nakanishi; Takahiro Tsuchikawa; Keisuke Okamura; Toru Nakamura; Eiji Tamoto; Takehiro Noji; Toshimichi Asano; Toraji Amano; Toshiaki Shichinohe; Satoshi Hirano
Journal:  HPB (Oxford)       Date:  2016-07-19       Impact factor: 3.647

7.  The Safety and Survival Outcome of Hepatectomy with Combined Bile Duct Resection for Colorectal Liver Metastasis.

Authors:  Takaaki Ito; Teiichi Sugiura; Yukiyasu Okamura; Yusuke Yamamoto; Ryo Ashida; Katsuhisa Ohgi; Hirofumi Yasui; Kentaro Yamazaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

Review 8.  Issues to be considered to address the future liver remnant prior to major hepatectomy.

Authors:  Yoji Kishi; Jean-Nicolas Vauthey
Journal:  Surg Today       Date:  2020-09-07       Impact factor: 2.549

Review 9.  Prognostic role of preoperative albumin-bilirubin score in posthepatectomy liver failure and mortality: a systematic review and meta-analysis.

Authors:  Shuai Zhou; Shuangchi Liu; Huichun Liu; Qing Pang; Zheng Lu
Journal:  Updates Surg       Date:  2021-05-19

10.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.